SOMERSET, N.J., Feb. 4, 2010 (GLOBE NEWSWIRE) -- inVentiv Selling Solutions, a division of inVentiv Health (Nasdaq:VTIV), today launched a new sales model, known as "Selling2Scale," to drive the commercial success of its clients' pharmaceutical products through strategic outsourcing solutions.
Selling2Scale leverages a proprietary methodology to assess and define the product opportunity, well beyond the traditional headcount models. This model identifies the sales and marketing resources that can be employed to deliver the most value in achieving a product's business goals and objectives. Using the model as a guide, the inVentiv Selling Solutions team then applies its expertise and experience to coordinate these resources in a truly integrated and customized way to maximize the commercial success of a product.
"Historically, clients asked us 'How many sales representatives do I need to effectively promote my product?' Today, as pharmaceutical companies continue to face a challenging and complex sales environment, clients are asking questions such as, 'What channels and touchpoints should I be employing to give my customers the information they want on the schedule they prefer?' and 'How can I maximize the return on my investment?' The Selling2Scale model is a comprehensive process that enables inVentiv to answer those questions with a customized, measurable plan tailored to meet the specific needs of each product," said Paul Mignon, President of inVentiv Selling Solutions.
Selling2Scale leverages the unparalleled breadth of personal and virtual resources across inVentiv Selling Solutions including recruiting, training, primary and specialty sales teams, clinical nurse educators, medical science liaisons, sample management, and closed loop marketing.
"Regardless of whether a pharmaceutical company is launching an innovative new therapy, trying to boost its market position, or simply sustaining product growth, Selling2Scale customizes the approach to help clients manage product challenges and achieve business success in a changing marketplace," added Mignon.
To learn more about Selling2Scale, go to www.inventivhealth.com/selling2scale or e-mail inVentiv Selling Solutions at selling2scale@inventivhealth.com.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com/">www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.